Llwytho...
Immunology /
A major revision of a classic textbook with every chapter brought fully up-to-date, incorporating every significant advance since the 1989 publication of the second edition. One specific advance covered is the development in understanding of the precise molecular interactions of the antibody-antigen...
Prif Awdur: | |
---|---|
Awduron Eraill: | , |
Fformat: | Printed Book |
Iaith: | English |
Cyhoeddwyd: |
Boston:
Mosby,
c1993.
|
Rhifyn: | 3rd ed. |
Pynciau: |
LEADER | 01715nam a22002297a 4500 | ||
---|---|---|---|
008 | 140123b xxu||||| |||| 00| 0 eng d | ||
020 | |a 9780397447657 | ||
082 | |a 616.079 | ||
100 | |a Roitt, Ivan | ||
245 | |a Immunology / |c Ivan Roitt, Jonathan Brostoff and David Male. | ||
250 | |a 3rd ed. | ||
260 | |a Boston: |b Mosby, |c c1993. | ||
300 | |a 25.16p.: |c 23cm. | ||
520 | |a A major revision of a classic textbook with every chapter brought fully up-to-date, incorporating every significant advance since the 1989 publication of the second edition. One specific advance covered is the development in understanding of the precise molecular interactions of the antibody-antigen binding site. Some chapters have been amalgamated (eg MHC, Immunoglobins and TCRS) to make room for two new chapters - immunodeficiency and cell migration and inflammation. The text and illustrations in all chapters have been thoroughly vetted by professional science writer Linda Gamlin. She aims to make the text accessible, rectifying criticisms levelled at the second edition of inconsistent style and over academic prose. It features clear page design and every illustration is close to its reference in the text. | ||
650 | |a Immunology. | ||
650 | 7 | |a Clinical immunology |2 fast |9 929866 | |
700 | |a Brostoff, Jonathan. | ||
700 | |a Male, David. | ||
942 | |2 ddc |c BK | ||
999 | |c 152507 |d 152507 | ||
952 | |0 0 |1 0 |4 0 |6 616_079000000000000_ROI_I |7 0 |9 163012 |a BIO |b BIO |c ST1 |d 2012-07-11 |g 850.00 |i 4 |l 2 |o 616.079 ROI/ I |p BIO4 |q 2022-01-12 |r 2021-12-13 |s 2021-12-13 |v 850.00 |w 2018-08-10 |y BK | ||
952 | |0 0 |1 0 |4 0 |6 616_079000000000000_ROI_I |7 0 |9 163013 |a BIO |b BIO |c ST1 |d 2015-10-05 |i 42 |l 5 |m 7 |o 616.079 ROI/ I |p BIO42 |r 2021-02-17 |s 2019-01-28 |w 2015-10-05 |y BK |